Susquehanna International Group’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.33M | Buy |
294,198
+242,030
| +464% | +$2.74M | ﹤0.01% | 1718 |
|
2025
Q1 | $602K | Buy |
52,168
+22,990
| +79% | +$265K | ﹤0.01% | 4099 |
|
2024
Q4 | $247K | Buy |
29,178
+11,357
| +64% | +$96.2K | ﹤0.01% | 4998 |
|
2024
Q3 | $206K | Buy |
17,821
+4,335
| +32% | +$50.2K | ﹤0.01% | 4781 |
|
2024
Q2 | $159K | Sell |
13,486
-6,400
| -32% | -$75.4K | ﹤0.01% | 4890 |
|
2024
Q1 | $236K | Sell |
19,886
-7,085
| -26% | -$84K | ﹤0.01% | 4493 |
|
2023
Q4 | $330K | Buy |
26,971
+16,177
| +150% | +$198K | ﹤0.01% | 4420 |
|
2023
Q3 | $104K | Sell |
10,794
-49,177
| -82% | -$474K | ﹤0.01% | 4906 |
|
2023
Q2 | $540K | Buy |
59,971
+25,906
| +76% | +$233K | ﹤0.01% | 3517 |
|
2023
Q1 | $268K | Sell |
34,065
-73,180
| -68% | -$575K | ﹤0.01% | 4540 |
|
2022
Q4 | $725K | Buy |
+107,245
| New | +$725K | ﹤0.01% | 2725 |
|
2022
Q3 | – | Hold |
0
| – | – | – | 6541 |
|
2022
Q2 | – | Sell |
-12,558
| Closed | -$185K | – | 6265 |
|
2022
Q1 | $185K | Sell |
12,558
-17,865
| -59% | -$263K | ﹤0.01% | 4874 |
|
2021
Q4 | $402K | Sell |
30,423
-10,449
| -26% | -$138K | ﹤0.01% | 4104 |
|
2021
Q3 | $713K | Buy |
40,872
+2,819
| +7% | +$49.2K | ﹤0.01% | 3215 |
|
2021
Q2 | $912K | Sell |
38,053
-27,967
| -42% | -$670K | ﹤0.01% | 3097 |
|
2021
Q1 | $1.7M | Sell |
66,020
-9,563
| -13% | -$246K | ﹤0.01% | 2308 |
|
2020
Q4 | $1.44M | Buy |
+75,583
| New | +$1.44M | ﹤0.01% | 2110 |
|
2019
Q3 | – | Sell |
-23,514
| Closed | -$521K | – | 4745 |
|
2019
Q2 | $521K | Sell |
23,514
-24,546
| -51% | -$544K | ﹤0.01% | 2876 |
|
2019
Q1 | $1.38M | Buy |
48,060
+239
| +0.5% | +$6.84K | ﹤0.01% | 1052 |
|
2018
Q4 | $944K | Buy |
+47,821
| New | +$944K | ﹤0.01% | 1541 |
|
2016
Q3 | – | Sell |
-4,583
| Closed | -$43K | – | 3464 |
|
2016
Q2 | $43K | Buy |
+4,583
| New | +$43K | ﹤0.01% | 3018 |
|